Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

Abstract Background Although total plasma lipoproteome consists of proteins that have shown promises as biomarkers that can identify Alzheimer’s disease (AD), effect sizes are modest. The objective of this study is to provide initial proof-of-concept that the plasma lipoproteome more likely differ b...

Full description

Bibliographic Details
Main Authors: Danni Li, Fangying Huang, Yingchun Zhao, Peter W. Villata, Timothy J. Griffin, Lin Zhang, Ling Li, Fang Yu
Format: Article
Language:English
Published: BMC 2018-09-01
Series:Clinical Proteomics
Subjects:
Alzheimer’s disease
Plasma lipoproteins
Targeted proteomics
Complement C3
Very low-density lipoprotein (VLDL)
Intermediate density lipoprotein (IDL)
Online Access:http://link.springer.com/article/10.1186/s12014-018-9207-z

Internet

http://link.springer.com/article/10.1186/s12014-018-9207-z

Similar Items